Fact Sheet for Healthcare Providers: Emory Medical Laboratories SARS-CoV-2 RBD IgG Test | NLM

Disaster Information Management Research Center | NLM

Fact Sheet for Healthcare Providers: Emory Medical Laboratories SARS-CoV-2 RBD IgG Test

06/15/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 6/15/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the SARS-CoV-2 RBD IgG test. The SARS-CoV-2 RBD IgG test is authorized for the detection of IgG antibodies to SARS-CoV-2 in human serum. (PDF)